Verve Therapeutics, Inc. Common Stock

VERV US92539P1012

💰
Capitalization
Small-cap

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

🔗
Website
https://www.vervetx.com
Annual Performance 1
2021 2022 2023 2024 2025
16% -51% -26% -60% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
10
🙍
Insiders
6
Person Price Shares Total Published Completed
Ashe Andrew D.
O 		4.15
USD 		2,681
Sold 		11,126
USD 		01/04/2025 02/04/2025
Kathiresan Sekar
CEO 		4.15
USD 		9,822
Sold 		40,761
USD 		01/04/2025 02/04/2025
Nickerson Joan
SR EXX 		4.15
USD 		2,777
Sold 		11,525
USD 		01/04/2025 02/04/2025
Dorval Allison
CFO 		4.15
USD 		3,350
Sold 		13,903
USD 		01/04/2025 02/04/2025
Lister Troy
CSO 		4.15
USD 		2,189
Sold 		9,084
USD 		01/04/2025 02/04/2025
Dorval Allison
CFO 		5.64
USD 		555
Sold 		3,130
USD 		29/11/2024 02/12/2024
Ashe Andrew D.
O 		6.26
USD 		76,000
Bought 		475,760
USD 		14/05/2024 14/05/2024
Nickerson Joan
SR EXX 		8.24
USD 		1,514
Sold 		12,475
USD 		01/04/2024 02/04/2024
Yeshwant Krishna
 10.00
USD 		1,800,000
Bought 		18,000,000
USD 		01/12/2023 01/12/2023
Dorval Allison
CFO 		11.45
USD 		554
Sold 		6,343
USD 		29/11/2023 29/11/2023
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Verve Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-0% -25% -59% -70% 0% 0% -82%
Last 52W Low 52W High All-Time Low All-Time High β
11.13 2.97 11.38 2.97 73.99
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Yeshwant Krishna 1 18,000,000.00 18,000,000.00 01/12/2023 01/12/2023
Ashe Andrew D. 2 486,886.15 243,443.08 14/05/2024 02/04/2025
Kathiresan Sekar 1 40,761.30 40,761.30 02/04/2025 02/04/2025
Nickerson Joan 2 23,999.91 11,999.95 02/04/2024 02/04/2025
Dorval Allison 3 23,376.00 7,792.00 29/11/2023 02/04/2025
Lister Troy 1 9,084.35 9,084.35 02/04/2025 02/04/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.